Old Web
English
Sign In
Acemap
>
authorDetail
>
Diletta Barbanotti
Diletta Barbanotti
Medicine
Virology
Internal medicine
human immunodeficiency virus
Cannabinoid receptor type 2
5
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
In vivo evidence that the cannabinoid receptor 2–63 RR variant is associated with the acquisition and/or expansion of HIV infection
2018
Hiv Medicine
Caterina Sagnelli
Caterina Uberti-Foppa
Hamid Hasson
Giulia Bellini
Carmine Minichini
Stefania Salpietro
Emanuela Messina
Diletta Barbanotti
M. Merli
Francesca Punzo
Nicola Coppola
Adriano Lazzarin
Evangelista Sagnelli
Francesca Rossi
Show All
Source
Cite
Save
Citations (4)
La terapia con i nuovi DAA in pazienti affetti da coinfezione HIV/HCV: esperienza di un centro@@@DAAs treatment in HIV/HCV coinfected patients: a single center experience
2017
Diletta Barbanotti
Emanuela Messina
Hamid Hasson
Liviana Della Torre
Concetta Vinci
Stefania Salpietro
Daniela Zandonà
Rossana Melzi
Sabrina Bagaglio
G. Morsica
Caterina Uberti-Foppa
Show All
Source
Cite
Save
Citations (0)
Cannabinoid receptor 2-63 RR variant is independently associated with severe necroinflammation in HIV/HCV coinfected patients
2017
PLOS ONE
Caterina Sagnelli
Caterina Uberti-Foppa
Hamid Hasson
Giulia Bellini
Carmine Minichini
Stefania Salpietro
Emanuela Messina
Diletta Barbanotti
M. Merli
Francesca Punzo
Nicola Coppola
Adriano Lazzarin
Evangelista Sagnelli
Francesca Rossi
Show All
Source
Cite
Save
Citations (8)
Real-Life Experience of Daa-Based Regimens Plus Ribavirin in Cirrhotic Patients Coinfected with HCV and HIV-1
2016
Journal of Hepatology
Emanuela Messina
Caterina Uberti-Foppa
M. Merli
Laura Galli
Diletta Barbanotti
Andrea Poli
Stefania Salpietro
G. Morsica
Sabrina Bagaglio
Andrea Andolina
Antonella Castagna
Adriano Lazzarin
Hamid Hasson
Show All
Source
Cite
Save
Citations (0)
1